#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	23326	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2113	1091.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1413	1413	C	1287	C,T	1241,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43574	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3488	1236.4	0	.	n	.	0	T695C	SNP	695	695	T	1052	1052	C	1315	C,G,T	1252,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43574	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3488	1236.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1694	1694	A	1486	A,G	1441,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43574	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3488	1236.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2328	2328	C	1290	C	1229	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43574	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3488	1236.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2402	2402	A	1270	A	1218	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43574	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3488	1236.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2954	2954	C	1332	C	1280	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	43574	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3488	1236.4	0	HET	.	.	.	A790G,T,C	.	790	790	A	1147	1147	A	1405	A,G,T,C	1054,292,1,1	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2732	folP	855	855	100.0	folP.l15.c4.ctg.1	1500	180.7	1	SNP	p	R229S	0	.	.	685	687	CGC	962	964	CGC	303;303;304	C;G;C	291;289;287	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	7484	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3276	226.3	1	SNP	p	S91F	0	.	.	271	273	TCC	513	515	TCC	244;242;243	T;C,G;C	231;230,1;231	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	7484	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3276	226.3	1	SNP	p	D95N	0	.	.	283	285	GAC	525	527	GAC	238;235;237	G;A;C	227;221;223	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	7484	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3276	226.3	1	SNP	p	D95G	0	.	.	283	285	GAC	525	527	GAC	238;235;237	G;A;C	227;221;223	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	2536	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1437	175.1	1	SNP	p	G45D	1	.	.	133	135	GAC	523	525	GAC	280;282;281	G;A;C	274;274;277	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1394	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	945	145.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	7446	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2941	250.5	1	SNP	p	D86N	0	.	.	256	258	GAC	603	605	GAC	292;292;296	G;A,C;C	284;281,1;285	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	7446	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2941	250.5	1	SNP	p	S88P	0	.	.	262	264	TCC	609	611	TCC	297;296;298	T;C;C	284;279;286	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5802	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2540	225.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1546	1548	GGC	300;299;292	G;G,T;C	285;286,1;275	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1265	1267	GCA	344;344;348	G;C;A	327;316;334	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1268	1270	ATC	349;353;349	A;T,G;C	334;331,1;332	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1280	1282	GTG	353;350;355	G;T,A;G	333;328,2;341	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1280	1282	GTG	353;350;355	G;T,A;G	333;328,2;341	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1784	1786	ACC	295;298;301	A,G;C;C	281,1;287;291	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1838	1840	GCG	274;273;275	G;C,T,G;G	258;221,10,3;260	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1838	1840	GCG	274;273;275	G;C,T,G;G	258;221,10,3;260	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1961	1963	GGC	225;226;226	G;G;C	212;210;210	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1970	1972	GGC	223;220;217	G,C,A;G;C	207,1,1;205;203	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5850	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2339	246.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1988	1990	CTG	206;205;203	C,G;TG,TGG;G,C	163,15;146,2;176,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	8878	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3127	281.2	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1691	1693	CCG	330;331;330	C;C;G,C	314;320;312,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3332	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1703	193.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	370	372	GGC	240;241;241	G;G;C	227;231;227	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3332	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1703	193.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	552	552	C	228	C,G	208,3	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	V75I	NONSYN	223	225	GTT	467	469	ATT	381;377;374	A,G;T;T	350,9;359;357	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	509	511	AGC	342;340;336	A;G,C;C	332;322,9;326	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	V98I	NONSYN	292	294	GTC	536	538	ATC	334;328;328	A,G;T;C	307,8;309;313	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	D121S	NONSYN	361	363	GAC	605	607	AGC	330;324;330	A,G;G,A;C	301,8;301,8;309	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	608	610	AAA	331;337;338	A;A;A,C	311;320;313,10	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	671	673	CAA	358;356;360	C,A;A;A,G	327,9;339;338,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	E212D	NONSYN	634	636	GAA	878	880	GAT	353;346;346	G;A,G;T,A	332;326,6;323,6	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	H213G	NONSYN	637	639	CAT	881	883	GGT	347;348;341	G,C;G,A;T,G,C	329,6;330,6;308,3,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	V215A	NONSYN	643	645	GTT	887	889	GCT	337;336;337	G;C;T	317;315;315	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	I218M	NONSYN	652	654	ATC	896	898	ATG	343;346;345	A;T;G,C,T	325;330;314,6,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1013	1015	ACG	363;362;364	A;C,G,T;G	352;336,14,1;353	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1019	1021	GTT	366;366;368	G;T,C,G;T	355;333,15,2;359	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1133	1135	AAC	338;337;339	A,G;A;C	324,6;324;329	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	4294	porB1b	1047	1047	97.99	porB1b.l15.c4.ctg.1	1520	279.6	1	SNP	p	G120K	0	.	.	358	360	GGC	602	604	GGC	322;322;327	G,A,C;G,A;C	288,8,3;300,8;314	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	16110	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4694	339.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1834	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1021	177.4	1	SNP	p	V57M	1	.	.	169	171	ATG	517	519	ATG	363;365;363	A;T;G	355;354;352	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
